Suven Life Sciences Board Meeting on 5th Nov'26 to Consider Q2 Results
Suven Life Sciences Ltd 路 Intimation 路 05 Nov 2026, 5:30 am
Suven Life Sciences Board Meeting on 5th Nov'26 to Consider Q2 Results Suven Life Sciences Limited has scheduled a Board of Directors meeting for 5th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. In accordance with insider trading regulations, the trading window for dealing in company securities has been closed since 1st Oct'26 and will remain closed until 48 hours following the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Suven Life Sciences Ltd
- Please find enclosed the Revised News Release of our company 路 16 Nov 2026
- Please find enclosed the News Release of our Company 路 16 Nov 2026
- Please find enclosed News Release of our Company 路 12 Nov 2026
- Monitoring Agency Report for the quarter ended 30th September, 2026 路 06 Nov 2026
- Un-audited financial results for the quarter and half year ended 30th September 2026 路 05 Nov 2026
- Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2026 路 05 Nov 2026
- Suven Life Sciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- SUVEN LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 05 Nov 2026
